Skip to main content
. 2016 Nov 30;1(2):112–121. doi: 10.1182/bloodadvances.2016000927

Figure 2.

Figure 2.

OS outcomes in PCSNL. (A) Survival in the entire cohort (2004-2012). (B) Survival stratified by year of diagnosis; P is derived from a log-rank test for trend. (C) Survival stratified by upfront treatment modality. Cell sizes <10 were suppressed according to the NCDB policy.